查询词典 patients

Results All patients had no bladder and urethra injury, no retropubic hematoma, After removal of catheters, 47 patients successfully voided without incontinence, detrusor instability to various degrees developed in 8 patients and were relieved by expectant treatment. 1 suffered urination difficulty and cured by releasing tension sling. All patients were followed up for 3 to 12 months (mean 6 months), neither recurrence of SUI nor lower urinary tract obstruction was found. No graft rejection and inflammation occurred.

结果 所有患者无膀胱、尿道损伤，无耻骨后血肿形成；47例患者术后拔除尿管均能自行排尿并满意控尿，8例患者出现不同程度不稳定膀胱症状，经对症处理缓解。1例出现排尿困难，经松解张力线后缓解，随访3~12个月，平均6个月，无SUL症状复发及排尿困难，无移植物排斤、感染发生。

METHODS: A retrospective analysis was performed in 76 patients underwent arthroscopic PCL reconstruction, with the use of B-TP-B autograft in 21 patients, B-TP-B allograft in 27 patients, semitendinosus tendon autograft in 28 patients.

回顾分析21例膝关节镜下自体骨-髌腱-骨移植、28例自体半腱肌腱移植和27例异体骨-髌腱-骨移植重建后交叉韧带的情况。

Anti-MOG and anti-MBP antibodies predicted more frequent and earlier relapses. Of 39 seronegative patients, nine (23%) had a relapse, and time to relapse was 45 13.7 months. Of 22 patients with anti-MOG and anti-MBP, 21 (95%) relapsed, and mean time to relapse was 7.5 4.4 months. Of 42 patients with only anti-MOG, 35 (83%) relapsed within 14.6 9.6 months P .001 for both comparisons with antibody-seronegative patients.

研究显示，抗MOG和抗MBP抗体可以预测更多和更早期的发作，39名血清呈阴性的患者中，9位(23%)复发，而重新发作的时间是45 ± 3.7个月，22名带有抗MOG和抗MBP的患者中，21名(95%)复发，复发时间为 7.5 ± 4.4个月，另外42名患者只有抗MOG，35人(83%)在 14.6 ± 9.6个月之内复发（P 。001，二组相较于血清呈阴性的患者）。

Anti-MOG and anti-MBP antibodies predicted more frequent and earlier relapses. Of 39 seronegative patients, nine (23%) had a relapse, and time to relapse was 45 13.7 months. Of 22 patients with anti-MOG and anti-MBP, 21 (95%) relapsed, and mean time to relapse was 7.5 4.4 months. Of 42 patients with only anti-MOG, 35 (83%) relapsed within 14.6 9.6 months P .001 for both comparisons with antibody-seronegative patients.

研究显示，抗MOG和抗MBP抗体可以预测更多和更早期的发作，39名血清呈阴性的患者中，9位(23%)复发，而重新发作的时间是45 ± 3.7个月，22名带有抗MOG和抗MBP的患者中，21名(95%)复发，复发时间为 7.5 ± 4.4个月，另外42名患者只有抗MOG，35人(83%)在 14.6 ± 9.6个月之内复发（P 。001，二组相较於血清呈阴性的患者）。

There were 41 colorectal stases in 22 patients, 13 hepatomas in seven patients, 37 neuroendocrine stases in six patients, and 41 noncolorectal stases in 15 patients.

其中有22位有41处直肠癌转移患者，7位有13处肝癌患者，6位有37处神经性癌转移患者和15位41处非结肠直肠转移患者。

Results Thirty-one(7.64%) of 406 patients showed abnormal ventilatory function, while 165 of 404 patients showed diffusing abnormality. Of the 434 patients who had received HRCT scans,151(34.79%) showed abnormalities including subpleural and basal ground-glass and reticular attenuation,nodular septal thickening and bronchiectasis. Of the 395 patients who had received both lung function test and HRCT scanning,55(13.92%) had abnormalities both in the lung function and HRCT.

结果 在4 0 6例进行肺通气功能检测的患者中，31例(7 6 4 %)异常；4 0 4例进行肺弥散功能检测，其中16 5例(40 84 %)异常；4 34例进行胸部HRCT检查，15 1例(34 79%)异常，表现为磨玻璃密度阴影、网格状阴影和胸膜下弧线影等；395例同时接受肺弥散功能检测和胸部HRCT检查，5 5例(13 92 %)两项均异常，且HRCT显示双肺病变典型者的肺弥散功能较HRCT正常者有显著的下降，两组差异有统计学意义。

2IVC:MRI showed the stenosis or occlusion of suprahepatic segment of the IVC in 9 patients,of them congenital abnormality was 4 patients,thrombosis was 3 patients and compression by tumor was 2 patients.

2IVC：MRI显示9例肝段IVC狭窄和阻塞，其中先天性膜或分隔形成2例，先天性狭窄或畸形2例，血栓形成1例，瘤栓形成2例，外压性狭窄2例。

All patients were performed open decompression operation on the legs with microincision.At the same time,the patients were given dehydration,diuresis drugs.The wounds were deferred the suturation time. Results:Among the 37 patients,33 patients were fully recovered.

均采用小切口减张术（即在小腿内、外侧各取纵行切口，长2~3cm，游离皮下组织直至深筋膜，打开深筋膜，将剪刀伸进切口内，分别向近、远端潜行剪开深筋膜，上至膝关节下，下至内踝）治疗。

Results Patients who had at least one abnormal result of liver function test accounted for 70.99% in untreated group and 61.07% in treated group. The most common abnormal hepatic function parameter in patients with thyrotoxic hepatic lesion was increased alkaline phosphate enzyme, which was 57.3% in untreated group and 51.0% in treated group. Abnormalities of alanine transaminase, aspartate transaminase, gamma-glutamyl tyanspeptidase and total bilirubin were 28.2%(37/131), 18.3%(24/131), 10.7%(14/131) and 21.4%(28/131) in untreated group and 21.5%(32/149), 15.4%(23/148), 4.7%(7/149) and 20.1%(30/149) in treated group, respectively. The possibility of thyrotoxic hepatic dysfunction was correlated with the patients' age and FT3 and FT4 levels, but not with the genesis and course of disease, sex, family history of hyperthyroidism, or levels of TGAb and TMAb. Conclusion Abnormal results of liver function test are commom in patients with hyperthyroidism.

结果 在未治组甲亢性肝功能损害的发生率为70.99%，经治组为61.07%；甲亢性肝功能损害最常见的异常指标是碱性磷酸酶增高，未治组、经治组分别为57.3%、51.0%；血清谷丙转氨酶异常在两组的发生率分别为28.2%、21.5%；血清谷草转氨酶异常在两组的发生率分别为18.3%、15.4%；总胆红素异常在两组的发生率分别为21.4%、20.1%；谷酰胺转肽酶异常的发生率未治组和经治组分别为10.7%、4.7%；甲亢性肝功能损害的发生与病程、甲状腺疾病家族史、性别、TGAb水平、TMAb水平无关，与年龄、甲状腺激素水平有关。

Moreover, after being followed up for 3 years, 49 patients who received regular SIT have less possibility to suffer from asthma than those of 23 cases patients who had irregular SIT, and the difference between them was statistically significant (P.01). For AR patients complicating with asthma, their asthmatic symptoms and physical signs had been improved after SIT. It was increasingly reduced for the level of TIgE, SIgE, and ECP in serum of AR patients after SIT.

此外，观察期满3年的49例接受系统免疫治疗的患者与未系统治疗患者23例发现，前者继发哮喘的几率低于后者，两者比较差异有统计学意义(P.01)；对合并有哮喘的AR患者经SIT后，哮喘症状体征有改善；患者血清TIgE、SIgE和ECP在SIT治疗后水平逐渐降低。

The split between the two groups can hardly be papered over.

这两个团体间的分歧难以掩饰。

This approach not only encourages a greater number of responses, but minimizes the likelihood of stale groupthink.

这种做法不仅鼓励了更多的反应，而且减少跟风的可能性。